"10.1371_journal.pone.0030269","plos one","2012-02-13T00:00:00Z","Stefan Bentink; Benjamin Haibe-Kains; Thomas Risch; Jian-Bing Fan; Michelle S Hirsch; Kristina Holton; Renee Rubio; Craig April; Jing Chen; Eliza Wickham-Garcia; Joyce Liu; Aedin Culhane; Ronny Drapkin; John Quackenbush; Ursula A Matulonis","Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America; Illumina, Inc., San Diego, California, United States of America; Department of Pathology, Division of Womans and Perinatal Pathology, Brigham and Womens Hospital, Boston, Massachusetts, United States of America; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America; Harvard School of Public Health, Boston, Massachusetts, United States of America; Harvard Medical School, Boston, Massachusetts, United States of America","Conceived and designed the experiments: JQ UAM. Performed the experiments: KH RR J-BF CA JC EW-G. Analyzed the data: SB BH-K TR JQ. Contributed reagents/materials/analysis tools: MSH JL JB-F SB BH-K AC RD. Wrote the paper: BH-K SB UAM JQ.","The assays used in deriving the angiogenic signature from patients at the Dana-Farber Cancer Institute and Brigham and Womens Hospital were performed by scientists at Illumina, who market the DASL. Authors Jian-Bing Fan, Craig April, Jing Chen and Eliza Wickham-Garcia are employed by Illumina, Inc., a commercial company. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials and all data have been deposited in ArrayExpress.","2012","02","Stefan Bentink","SB",15,TRUE,2,6,4,4,TRUE,TRUE,FALSE,0,NA,FALSE
